Advanced Medical Isotope Revenue 2013-2023 | RDGL

Advanced Medical Isotope revenue from 2013 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Advanced Medical Isotope Annual Revenue
(Millions of US $)
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
Advanced Medical Isotope Quarterly Revenue
(Millions of US $)
2023-12-31
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31
2021-09-30 $0
2021-06-30
2021-03-31
2020-12-31
2020-09-30 $0
2020-06-30
2020-03-31
2019-12-31 $0
2019-09-30 $0
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31 $0
2016-12-31 $-0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30
2015-03-31 $0
2014-12-31
2014-09-30
2014-06-30 $0
2014-03-31 $0
2013-12-31 $-0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
Sector Industry Market Cap Revenue
Finance Finance - SBIC & Commercial $0.078B $0.000B
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) United States $12.824B 8.83
Blackstone Secured Lending Fund (BXSL) United States $6.085B 8.23
FS KKR Capital (FSK) United States $5.565B 6.49
Main Street Capital (MAIN) United States $4.198B 11.57
Hercules Capital (HTGC) United States $3.227B 9.43
Golub Capital BDC (GBDC) United States $2.869B 8.58
Morgan Stanley Direct Lending Fund (MSDL) United States $1.979B 8.34
Goldman Sachs BDC (GSBD) United States $1.785B 6.89
New Mountain Finance (NMFC) United States $1.341B 8.14
BARINGS BDC, INC (BBDC) United States $1.030B 8.03
Nuveen Churchill Direct Lending (NCDL) United States $0.956B 0.00
BLACKROCK TCP CAPITAL CORP (TCPC) United States $0.911B 5.72
Carlyle Secured Lending (CGBD) United States $0.906B 8.33
SLR Investment (SLRC) United States $0.884B 9.42
Amalgamated Financial (AMAL) United States $0.780B 8.44
Trinity Capital (TRIN) United States $0.736B 6.79
Crescent Capital BDC (CCAP) United States $0.674B 7.61
CION Investment (CION) United States $0.652B 6.12
Fidus Investment (FDUS) United States $0.632B 7.88
Palmer Square Capital BDC (PSBD) United States $0.535B 0.00
Gladstone Investment (GAIN) United States $0.522B 14.36
Gladstone Capital (GLAD) United States $0.482B 11.25
PennantPark Investment (PNNT) United States $0.475B 6.93
Runway Growth Finance (RWAY) United States $0.456B 5.96
Horizon Technology Finance (HRZN) United States $0.415B 6.23
TriplePoint Venture Growth BDC (TPVG) United States $0.349B 4.73
Stellus Capital Investment (SCM) United States $0.345B 7.37
Saratoga Investment Corp (SAR) United States $0.317B 5.63
WhiteHorse Finance (WHF) United States $0.296B 6.89
Oxford Square Capital (OXSQ) United States $0.192B 6.71
Medallion Financial (MFIN) United States $0.187B 3.76
OFS Capital (OFS) United States $0.129B 6.21
PhenixFIN (PFX) United States $0.096B 18.05
Silver Spike Investment (SSIC) United States $0.070B 13.45
Logan Ridge Finance (LRFC) United States $0.060B 16.03
Investcorp Credit Management BDC (ICMB) United States $0.047B 5.53
Bain Capital Specialty Finance (BCSF) United States $0.000B 7.51
Rand Capital (RAND) United States $0.000B 11.26